Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

CCOLLEGIUM PHARMACEUTICAL, INC

EconomyAI buildoutMarket MapFundsWatchlist
Log in
C

COLLEGIUM PHARMACEUTICAL, INC

$22.78Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • Insider Transactions
Loading financials
Income statement waterfall. Revenue $199.88M. Net result −$15.05M. A thin axis line marks the loss-zone boundary.

Income statement waterfall. Green diagonal stripes add to the running result, red diagonal stripes subtract from it, and a thin axis line marks the loss-zone boundary.

  • Revenue: $199.88M. Running result $199.88M. Azstarys: $12.91M. Belbuca: $57.67M. Jornay Pm: $46.06M. Nucynta ERAG: $2.78M. Nucynta ER: $15.72M. Nucynta IRAG: $2.36M. Nucynta IR: $14.36M. Symproic: $3.02M. Xtampza ER: $45.01M.
  • Cost of revenue: −$89.59M. Running result $110.29M.
  • Gross profit: $110.29M. Running result $110.29M.
  • Selling, general and administrative: −$106.59M. Running result $3.7M.
  • Gain on fair value remeasurement of contingent consideration: $0. Running result $3.7M.
  • Operating income: $3.7M. Running result $3.7M.
  • Other expense: −$17.23M. Running result −$13.53M.
  • Pre-tax loss: −$13.53M. Running result −$13.53M.
  • Income tax expense: −$1.52M. Running result −$15.05M.
  • Net loss: −$15.05M. Running result −$15.05M.